Board of Directors

Director of Market Access and Corporate Affairs at Merck since 2015. She is also a member of FEI (Forum of Innovative Companies), of the Board of Directors of the Digital Health Association and Dr. of the Executive Committee of CLOSINGAP.

General Director at Ingenasa, a company specializing in biotechnology for the veterinary sector, which she joined in 1994 as marketing director.

CEO at Arrays for Cell Nanodevices, SL

CSO at Zeclinics

General Director at 3P Biopharmaceuticals since 2007, Dámaso Molero has a long experience in pharmaceutical production, with more than 10 years as a plant manager in Shionogi

Director of Market Access and Governance at AbbVie since 2013. He had been previously Director of Health Management and Institutional Relations at Abbott Laboratories and General Director of the company's foundation.

CEO and Vice President of Business Development and Licensing at Ability Pharma since 2009. At the same time, he has been a consultant for biotech projects of the investment company Kieretsu Forum Spain.

President and CEO of AlgaEnergy, a company designed to create products derived from microalgae. He leads R+D+i projects in microalgae biotechnology.

CEO at Advanced Maker Discovery

Executive Chairman of the Board at Atrys Health. Torres, a physician specializing in Clinical Pharmacology, is also part of the board of various organizations with social purposes.

Head of Innovation for Spain, Portugal and Latin America at Ayming, a company she joined in 2007 as a senior R&D consultant.

Director of Agricultural Policies and Institutional Relations at Bayer Crop Science Iberia, the agro division of the multinational, which is the third largest company in the world in products for agriculture.

Co-founder and president since 2001 of the investment company Cross Road Biotech, Castellón was Secretary of State for Health and Consumer Affairs (1996-2000), a position from which he promoted multiple projects of great relevance to the sector.

Director Corporate Affairs

CEO at Science & Innovation Link Office (SILO)

CEO at Vivebiotech

Founding partner and CEO at Vivia Biotech, a company specializing in drug screening, which he joined after 10 years working as a lawyer in the United States.